Bone Marrow Transplantation for Genetic Diseases

William Krivit, Chester B. Whitley

Research output: Contribution to journalEditorial

31 Citations (Scopus)

Abstract

Four recent editorials in the Journal have reviewed the potential for increasing the therapeutic armamentarium for genetic disease.1 2 3 4 Bone marrow transplantation has been considered in each of these editorials. Now, in this issue of the Journal, Lucarelli et al. present impressive data on the use of marrow transplantation for the treatment of β-thalassemia.5 In severely affected patients 8 to 15 years of age, functional engraftment as measured by correction of the hematologic abnormality has been produced. In the future, clinical success will be measured by continued freedom from hemolysis and the necessity of repeated transfusions, resulting in an eventual…

Original languageEnglish (US)
Pages (from-to)1085-1087
Number of pages3
JournalNew England Journal of Medicine
Volume316
Issue number17
DOIs
StatePublished - Apr 23 1987

Fingerprint

Inborn Genetic Diseases
Bone Marrow Transplantation
Hemolysis
Transplantation
Bone Marrow
Therapeutics

Cite this

Bone Marrow Transplantation for Genetic Diseases. / Krivit, William; Whitley, Chester B.

In: New England Journal of Medicine, Vol. 316, No. 17, 23.04.1987, p. 1085-1087.

Research output: Contribution to journalEditorial

@article{9a1a09313b2b4c10a1bc2c4f2987fae2,
title = "Bone Marrow Transplantation for Genetic Diseases",
abstract = "Four recent editorials in the Journal have reviewed the potential for increasing the therapeutic armamentarium for genetic disease.1 2 3 4 Bone marrow transplantation has been considered in each of these editorials. Now, in this issue of the Journal, Lucarelli et al. present impressive data on the use of marrow transplantation for the treatment of β-thalassemia.5 In severely affected patients 8 to 15 years of age, functional engraftment as measured by correction of the hematologic abnormality has been produced. In the future, clinical success will be measured by continued freedom from hemolysis and the necessity of repeated transfusions, resulting in an eventual…",
author = "William Krivit and Whitley, {Chester B.}",
year = "1987",
month = "4",
day = "23",
doi = "10.1056/NEJM198704233161710",
language = "English (US)",
volume = "316",
pages = "1085--1087",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "17",

}

TY - JOUR

T1 - Bone Marrow Transplantation for Genetic Diseases

AU - Krivit, William

AU - Whitley, Chester B.

PY - 1987/4/23

Y1 - 1987/4/23

N2 - Four recent editorials in the Journal have reviewed the potential for increasing the therapeutic armamentarium for genetic disease.1 2 3 4 Bone marrow transplantation has been considered in each of these editorials. Now, in this issue of the Journal, Lucarelli et al. present impressive data on the use of marrow transplantation for the treatment of β-thalassemia.5 In severely affected patients 8 to 15 years of age, functional engraftment as measured by correction of the hematologic abnormality has been produced. In the future, clinical success will be measured by continued freedom from hemolysis and the necessity of repeated transfusions, resulting in an eventual…

AB - Four recent editorials in the Journal have reviewed the potential for increasing the therapeutic armamentarium for genetic disease.1 2 3 4 Bone marrow transplantation has been considered in each of these editorials. Now, in this issue of the Journal, Lucarelli et al. present impressive data on the use of marrow transplantation for the treatment of β-thalassemia.5 In severely affected patients 8 to 15 years of age, functional engraftment as measured by correction of the hematologic abnormality has been produced. In the future, clinical success will be measured by continued freedom from hemolysis and the necessity of repeated transfusions, resulting in an eventual…

UR - http://www.scopus.com/inward/record.url?scp=0023662843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023662843&partnerID=8YFLogxK

U2 - 10.1056/NEJM198704233161710

DO - 10.1056/NEJM198704233161710

M3 - Editorial

VL - 316

SP - 1085

EP - 1087

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 17

ER -